<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Verhoef, J.</title>
    <link>http://repub.eur.nl/res/aut/11721/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Long-term carriage, and transmission of methicillin-resistant Staphylococcus aureus after discharge from hospital (Article)</title>
      <link>http://repub.eur.nl/res/pub/6978/</link>
      <pubDate>1992-11-01T00:00:00Z</pubDate>
      <description>The purpose of this study was to determine whether patients who become carriers of methicillin-resistant Staphylococcus aureus (MRSA) during their stay in hospital, remain colonized after discharge. Thirty-six patients colonized with MRSA during one of three outbreaks at Utrecht University Hospital (1986-89) were screened 2 or 3 years after they had become carriers. Patients were also interviewed to determine factors contributing to persistent carriage, such as antibiotics, re-admissions to the hospital, presence of skin lesions and chronic diseases. At the same time transmission of MRSA to family members was determined. The epidemic MRSA strain was still found in three patients (8%). One was a cystic fibrosis patient who had had frequent re-admissions to the hospital and had received several course of antibiotic treatment. Both of the other patients had skin lesions: a fistula and a colostomy respectively. None of the 44 family members of the patients was colonized or infected with MRSA. We conclude that long-term MRSA carriage occurs with low frequency and is comparable to persistent carriage of methicillin-sensitive Staphylococcus aureus (MSSA). Transmission of MRSA to healthy individuals in an antibiotic-free environment is a rare event.</description>
    </item> <item>
      <title>Antibodies to Cell Wall Peptidoglycan of Staphylococcus aureus in Patients with Serious Staphilococcal Infections (Article)</title>
      <link>http://repub.eur.nl/res/pub/12464/</link>
      <pubDate>1981-07-01T00:00:00Z</pubDate>
      <description>An enzyme-linked immunoassay was used to detect antibodies to the cell wall
peptidoglycan of Staphylococcus aureus in human sera. All 170 sera from donors
and patients with staphylococcal and nonstaphilococcal infections contained IgG
antibodies to peptidoglycan; antobody levels varied with age, and
transplacental transfer occurred. IgM antibodies to peptidoglycan were not
found in donors and were present in only one patient with serious
staphylococcal infection. Significantly elevated levels of IgG antibodies to
peptidoglycan were observed in 20 (80%) of 25 patients with deep tissue
infection with S. aureus but in only two (9%) of 22 patients with superficial
staphylococcal infection. An increase in levels of antibodies to peptidoglycan
generally coincided with an increase in level of IgG antibodies to teichoic
acid. No cross-reactivity between peptidoglycan and teichoic acid was
observed. Thus, staphylococcal peptidoglycan is immunogenic in humans, and
testing for IgG antibodies to peptidoglycan may be useful in the diagnosis and
follow-up of serious staphylococcal infections.</description>
    </item>
  </channel>
</rss>